Butaclamol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3-(1,1-dimethylethyl)-2,3,4,4a,8,9, 13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 36504-93-5 |
| ATC code | None |
| PubChem | CID 37459 |
| IUPHAR ligand | 62 |
| ChemSpider | 34364 |
| UNII | A7A2802VNL |
| ChEMBL | CHEMBL479587 |
| Chemical data | |
| Formula | C25H31NO |
| Mol. mass | 361.52 g/mol |
| SMILES | eMolecules & PubChem |
Butaclamol (AY-23,028) is an antipsychotic which was never marketed.[1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist. [2]
[edit] See also
[edit] References
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

